Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to $9.1 million.

  • Janux Therapeutics' Prepaid Assets rose 968.64% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 968.64%. This contributed to the annual value of $8.5 million for FY2024, which is 6291.96% up from last year.
  • Per Janux Therapeutics' latest filing, its Prepaid Assets stood at $9.1 million for Q3 2025, which was up 968.64% from $9.5 million recorded in Q2 2025.
  • In the past 5 years, Janux Therapeutics' Prepaid Assets ranged from a high of $9.5 million in Q2 2025 and a low of $2.0 million during Q2 2021
  • Its 5-year average for Prepaid Assets is $5.8 million, with a median of $5.5 million in 2022.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 72489.96% in 2021, then tumbled by 387.24% in 2023.
  • Quarter analysis of 5 years shows Janux Therapeutics' Prepaid Assets stood at $2.1 million in 2021, then surged by 164.02% to $5.4 million in 2022, then decreased by 3.87% to $5.2 million in 2023, then soared by 62.92% to $8.5 million in 2024, then increased by 7.06% to $9.1 million in 2025.
  • Its Prepaid Assets stands at $9.1 million for Q3 2025, versus $9.5 million for Q2 2025 and $9.2 million for Q1 2025.